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Abstract 
Background: Previous studies have indicated that the majority 
of cancer patients have used self-selected Complementary and 
Alternative Medicine to relieve disease-related symptoms and 
treatment-related adverse effects untreated by conventional 
treatment to improve the quality of life. Unfortunately, studies 
on Complementary and Alternative Medicine use among cancer 
patients, especially in Yogyakarta, the city with the highest 
cancer prevalence in Indonesia, are still limited.  
Objective: This present study aims to identify the correlation 
between being informed on Complementary and Alternative 
Medicine and its reported use among cancer patients.  
Methods: This study was a descriptive correlational study on 75 
consenting cancer patients. The respondents were selected 
using a purposive sampling technique. Data about their 
Complementary and Alternative Medicine use were collected by 
administered questionnaires and analyzed using descriptive 
statistics and bivariate analysis.  
Results: 25.3% of respondents had used Complementary and 
Alternative Medicine. Being informed on Complementary and 
Alternative Medicine and its reported use among cancer 
patients were significantly correlated (r=0.331; p=0.002).  
Conclusion: Complementary and Alternative Medicine use 
among cancer patients was still limited. Health providers need 
to discuss Complementary and Alternative Medicine use with 
their patients openly. 
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Cancer is categorized as one of the non-
communicable diseases, with its prevalence 
reaching 1.8% per 1,000 population in Indonesia. 
The highest cancer prevalence in Indonesia has 
occurred in the Yogyakarta Special Region, reaching 
4.9% per 1,000 population for all ages (Ministry of 
Health Republic Indonesia, 2018). 
 
Cancer patients could experience physical and 
psychological problems while undergoing treatment 
for their illness in the hospital (American Cancer 
Society, 2017; Dy & Apostol, 2010; Effendy et al., 
2014). The most common physical symptoms are 
fatigue, pain, sleep disturbance, nausea, vomiting, 
and decreased immune function. Also, the 
psychological symptoms are anxiety, depression, 
fear of the illness’s severity, fear of going through 
disease examination, fear of having repeated 
relapse of the illness, and death (Effendy et al., 
2014). 
 





Complementary and Alternative Medicine (CAM) 
emerges as one of the options favored by cancer 
patients at a different stage of the diagnosis and 
treatment, ranging from 30% to 50% of patients 
during adjuvant chemotherapy or radiotherapy, 
perioperative, and palliative phases (Ben-Arye et al., 
2014; Shin et al., 2012). CAM is a various system, 
practice, and medical and health product commonly 
understood as non-conventional treatment 
(National Center for Complementary and 
Alternative Medicine, 2011). Cancer patients use 
CAM because it is easy and affordable, with no side 
effects, and their belief in the positive effects of 
CAM (Almasdy et al., 2018). 
 
The use of CAM is based on the patients' 
sociodemographics, the clinical characteristics of 
the cancer patients, cultural factors, and the 
patients' coping patterns associated with the 
disease. As many as 25.5% of 2.661 respondents 
were reported using CAM (Shin et al., 2012). High 
income, metastasis, longer diagnosed time, low 
trust in the hospital, low satisfaction, and a higher 
need for information were related significantly to 
the use of CAM (Shin et al., 2012). Other studies also 
discussed that younger age, being in a stable 
relationship, a normal BMI (Paepke et al., 2020), and 
a higher educational level were predictors of the use 
of CAM (Gentry-Maharaj et al., 2017; Paepke et al., 
2020). 
 
Correlation between knowledge about CAM and its 
use, whether being used with or without the 
accompaniment of conventional treatment, 
becomes significant to be identified because cancer 
patients are often faced with more complex 
psychological and physiological situations compared 
to other non-communicable diseases (Shin et al., 
2012). In Indonesia, especially Yogyakarta, to date, 
almost no nationwide studies have reported CAM 
use. Data obtained from Padang, Indonesia, 
reported that 65% of patients had used CAM 
(Almasdy et al., 2018). Nurses also play an essential 
role in exploring the use of CAM and improving the 
cancer patients' understanding of CAM in terms of 
its procedure and the reason for its use. This present 
study aims to identify the correlation between the 
experience of getting information about CAM and 
its use among cancer patients. 
 
METHODS  
Setting and population 
This study was a descriptive correlative study using 
a cross-sectional approach. Data were collected 
from oncological and surgical outpatient wards at 
one of the general hospitals in the Special Region of 
Yogyakarta from July to August 2019 and selected 
using purposive technique sampling. Analyses 
included adults (older than 18 years) with all types 
of cancer who have had surgery and or were 
undergoing chemotherapy or radiotherapy 
treatment and willing to consent to participate in 
this study, excluding patients who suddenly 
experienced the emergency status. The cancer 
patients who met inclusion and exclusion criteria 
were identified through the medical record. After 
being identified as respondent candidates, they 
were fully informed about the study’s purpose and 
signed the informed consent. A total of 75 
consenting patients formed our final sample. They 
completed the questionnaires assisted by the 
researchers and two research assistants. 
 
Measure 
A questionnaire survey was designed to collect data 
about CAM use and demographic characteristics 
(age, gender, education, health insurance, marital 
status, the number of symptoms, stage of cancer, 
metastasis, and the experience of getting 
information about CAM). We defined CAM based on 
the widely established NCCAM taxonomy (National 
Center for Complementary and Alternative 
Medicine, 2011). The specific CAMs questioned in 
this study were herbs and vitamin supplements; 
spiritual healing or therapy; massage; relaxation 
technique, imagery, or yoga; lifestyle diets, music 
therapy; acupuncture or acupressure; hypnosis; and 
an open question about the other kinds of CAM. A 
positive response to at least one question in the 
questionnaire determined the respondent's 
classification as a CAM user. In contrast, a negative 
response to all questionnaire items led to the 
respondent's classification as a non-user. The 
number of symptoms was measured using the 
Edmonton Symptom Assessment System (ESAS) 
(Watanabe et al., 2012) and categorized into a 
dichotomous variable (less than five symptoms and 
more than five symptoms). 
 
  




First, we determined the prevalence of total age, 
gender, education, health insurance, marital status, 
the number of symptoms, stage of cancer, 
metastasis, the experience of getting information 
about CAM, and CAM use using descriptive analysis. 
Next, we used the contingency coefficient test to 
identify the correlation between being informed 
about CAM and its reported use with p<0.05 
indicating significance. All statistical analyzes were 
performed using the Statistical Package for the 
Social Sciences (SPSS) version 16 (SPSS Inc., 2007). 
 
Ethical consideration 
The Health Research Ethics Committee, Faculty of 
Health, Universitas Jenderal Achmad Yani 
Yogyakarta, approved this study (Number: 
Skep/068/KEPK/V/2019). All the patients gave their 




General characteristic of cancer patients 
Most of the respondents were between 40 to 60 
years old (53.3%), women (81.3%), married (85.3%), 
educational background varied between 
Elementary School and Senior High School levels, 
only 1.4% and 98.7% of them owned health 
insurance. Meanwhile, based on the characteristics 
of the illness, from 75 cancer patients being the 
respondents, most of them experienced less than 
five symptoms (58.7%), categorized into stage III of 
cancer (42.7%), had no metastasis (54.7%), and had 
never received any information about CAM (96.0%). 
The characteristics of the respondents are 
summarized in Table 1. 
  
CAM use 
The majority of the respondents did not use CAM, 
totaling 56 respondents (74.7%). CAM use among 
cancer patients is displayed in Table 2.  
 
The most frequent types of CAM used by the 
respondent were herbs and vitamin supplements 
(12 respondents), followed by 
acupuncture/acupressure (six respondents). The 
remaining were massage, spiritual healing or 
therapy, relaxation technique, imagery or yoga, 
physiotherapy, music therapy, and lifestyle diets. In 
this case, eight respondents used more than one 
kind of CAM. The combinations of CAM they used 
were herbs and vitamin supplements with 
acupuncture, massage, music therapy, or spiritual 
therapy. The types of CAM used by 19 respondents 
are listed in Figure 1. 
 
Correlation between being informed on CAM and its 
reported use 
There was a significant correlation between being 
informed on CAM and its reported use among 
cancer patients. The bivariate analysis was 
demonstrated in Table 3. 
 
DISCUSSION 
In this study, 19 cancer patients (25.3%) used CAM. 
Several research studies have suggested the use of 
CAM (Berretta et al., 2017; John et al., 2016; Klafke 
et al., 2012; Pihlak et al., 2014; Shin et al. 2012). This 
result is in line with the study by Shin et al. (2012) 
conducted on 2,661 cancer patients in Korea, in 
which 25.5 % of respondents used CAM. The low use 
of CAM was also seen in Israel in a study conducted 
by Ben-Arye et al. (2014), in which from 313 cancer 
patients, 39.6% of them used CAM. This number is 
still considered low compared to the use of CAM in 
Australia (61.5%) (Klafke et al., 2012) and in the 
United States (79%) (John et al., 2016). 
 
The high number of patients who did not use CAM 
may be due to the unclear description and efficacy 
of CAM since 96% of respondents in this study were 
not informed about CAM. In this study, 25.3% of 
CAM users utilized this treatment based on the 
information obtained from health care providers 
and mostly obtained information from friends and 
neighbors through word-of-mouth information 
exchange. This result assertion follows the study 
conducted by Almasdy et al. (2018), stating that the 
information about CAM was not from health care 
providers but friends or family (70.91%). 
Meanwhile, only 5.45% of the patients obtained 
information from healthcare providers (Almasdy et 
al., 2018). 
 
Herbs and vitamin supplements were the most used 
type of CAM by the respondents; the number was 
63.16 % from 19 respondents. This result is in line 
with a study conducted by Ezeome & Anarado 
(2007) in Nigeria, showing that, from 160 
respondents who participated in the study, 51.9% of 
them used herbs intended for treatment. A study by 
Field et al. (2009) also presented similar data, in 
which 54.4% out of 892 women with breast cancer 
in Australia and New Zealand used CAM in the form 





of supplements or vitamins. The use of herbs has 
also been confirmed as the most used CAM (92.72%) 
in a study by Almasdy et al. (2018) in Padang, 
Indonesia, conducted on 85 breast cancer patients. 
 
Herbs and vitamin supplements became the most 
used CAM due to their availability in the market and 
the easy access in obtaining them for people living 
in either rural or urban areas (Almasdy et al., 2018; 
Frenkel et al., 2013). Compared to other types of 
CAM, the use of herbs has increased in number 
because of their popularity and the cultural factors 
related to the use of natural products (Almasdy et 
al., 2018). Another factor was its low price due to 
the patients’ belief that natural products were safe 
for the body (Almasdy et al., 2018). The patients’ 
belief was the main reason for the CAM use because 
there were four phases of the CAM use decision-
making process. The first phase was fitting with the 
cultural belief lifestyle before seeking information 
and clarification about CAM, evaluating the 
effectiveness of the CAM use, and balancing the cost 
and benefit (Chiu et al., 2006). 
 
The patients used herbs and vitamin supplements to 
reduce the side effects of chemotherapy, organ 
toxicity, stimulate the immune system, or prevent 
further growth and relapse of cancer (Frenkel et al., 
2013). However, herbs and vitamin supplements 
were often consumed without recommendation 
and supervision from health care providers. As a 
result, misunderstandings related to the use of 
herbs and vitamin supplements between health 
care providers and patients emerge, in which this 
type of CAM has been considered as an unreliable 
treatment (Frenkel et al., 2013). 
 
There was a significant correlation between 
knowledge about CAM indicated by their experience 
of obtaining information about CAM and CAM use 
among cancer patients (r=0.331; p=0.002). The 
majority of the patients using CAM have not 
possessed any experience in given information on 
the use of CAM; the number was 16 respondents 
(84.2%). Only three respondents obtained 
information about the use of CAM from healthcare 
providers and used CAM. The case is different in the 
study by Dogu et al. (2014). It was conducted on 494 
cancer patients in Turkey, in which 78.6% of patients 
had obtained information related to CAM from 
health care providers. The rest of them gained 
information from friends and family (Dogu et al., 
2014). Information related to the use of CAM is an 
attempt to empower the patients to perform self-
care management. A small number of patients 
rejected the information related to CAM, fearing 
that this additional option might be interfering with 
their decision to select the ongoing treatment 
(Evans et al., 2007). 
 
Health care providers should discuss CAM openly 
with patients. Patients must report CAM use they 
perform alongside the convention treatment to 
prevent misunderstanding between the health care 
providers and them regarding CAM use. 
 
This study has limitations, namely the sample size 
supposed to be higher. This condition was due to the 
limited number of cancer patients in the study area. 
This study also did not provide the health care 
providers’ knowledge about CAM that needed to be 
explored as the factors affecting CAM use. However, 
this study provided the essential data and had a low 
level of missing data indicating the fit analyses. 
 
CONCLUSION 
This research outcome has generated new 
perspectives on CAM use by cancer patients. The 
few cancer patients informed about CAM have 
resulted in a limited effect on the use of CAM. CAM 
must be freely shared with patients by health care 
professionals. To avoid confusion between the 
health care providers and the patients about CAM 
use, the patients must disclose the use of CAM they 
carry out alongside convention therapy. Further 
research needs to explore the awareness of CAM by 
health care professionals to enrich the data on 
factors affecting CAM use in cancer patients. 
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Table 1. General characteristics of cancer patients (n=75) 
Characteristics n (%) 
Ages 
<40 years old 
40-60 years old 






















Junior high school 











































Table 2. CAM use among cancer patients (n=75) 













Table 3. Correlation between being informed on CAM and its reported use (n=75) 
Variable 




















*p<0.05 indicates significant 
 
 
Figure 1. Types of CAM 
 
